These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10811119)

  • 1. Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.
    Kim S; Wu HG; Shin JH; Park HJ; Kim IA; Kim IH
    Cancer Res Treat; 2005 Jun; 37(3):191-5. PubMed ID: 19956502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool.
    Suhail M; AlZahrani WM; Shakil S; Tarique M; Tabrez S; Zughaibi TA; Rehan M
    Front Pharmacol; 2023; 14():1236173. PubMed ID: 37900167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma.
    Bröckelmann PJ; de Jong MRW; Jachimowicz RD
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleus size and DNA accessibility are linked to the regulation of paraspeckle formation in cellular differentiation.
    Grosch M; Ittermann S; Rusha E; Greisle T; Ori C; Truong DJ; O'Neill AC; Pertek A; Westmeyer GG; Drukker M
    BMC Biol; 2020 Apr; 18(1):42. PubMed ID: 32321486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and Indirect Targeting of HOXA9 Transcription Factor in Acute Myeloid Leukemia.
    Lambert M; Alioui M; Jambon S; Depauw S; Van Seuningen I; David-Cordonnier MH
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31213012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Transcription Factors for Cancer Treatment.
    Lambert M; Jambon S; Depauw S; David-Cordonnier MH
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29921764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Karenitecin (bnp1350) and flavopridol as radiosensitizers in malignant glioma.
    Rajesh D; Robins HI; Howard SP
    J Neurol Neuromedicine; 2016; 1(6):1-10. PubMed ID: 28111642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavones: From Biosynthesis to Health Benefits.
    Jiang N; Doseff AI; Grotewold E
    Plants (Basel); 2016 Jun; 5(2):. PubMed ID: 27338492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism.
    Lu H; Xue Y; Yu GK; Arias C; Lin J; Fong S; Faure M; Weisburd B; Ji X; Mercier A; Sutton J; Luo K; Gao Z; Zhou Q
    Elife; 2015 Jun; 4():e06535. PubMed ID: 26083714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL).
    Maddocks K; Wei L; Rozewski D; Jiang Y; Zhao Y; Adusumilli M; Pierceall WE; Doykin C; Cardone MH; Jones JA; Flynn J; Andritsos LA; Grever MR; Byrd JC; Johnson AJ; Phelps MA; Blum KA
    Am J Hematol; 2015 Apr; 90(4):327-33. PubMed ID: 25639448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co-activation.
    Gardini A; Baillat D; Cesaroni M; Shiekhattar R
    EMBO J; 2014 Apr; 33(8):890-905. PubMed ID: 24591564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261.
    Bible KC; Peethambaram PP; Oberg AL; Maples W; Groteluschen DL; Boente M; Burton JK; Gomez Dahl LC; Tibodeau JD; Isham CR; Maguire JL; Shridhar V; Kukla AK; Voll KJ; Mauer MJ; Colevas AD; Wright J; Doyle LA; Erlichman C; ;
    Gynecol Oncol; 2012 Oct; 127(1):55-62. PubMed ID: 22664059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms.
    Holkova B; Perkins EB; Ramakrishnan V; Tombes MB; Shrader E; Talreja N; Wellons MD; Hogan KT; Roodman GD; Coppola D; Kang L; Dawson J; Stuart RK; Peer C; Figg WD; Kolla S; Doyle A; Wright J; Sullivan DM; Roberts JD; Grant S
    Clin Cancer Res; 2011 May; 17(10):3388-97. PubMed ID: 21447728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.
    Turinetto V; Porcedda P; Orlando L; De Marchi M; Amoroso A; Giachino C
    BMC Cancer; 2009 Aug; 9():281. PubMed ID: 19674456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive principles in the bark of Pilidiostigma tropicum.
    Setzer WN; Rozmus GF; Setzer MC; Schmidt JM; Vogler B; Reeb S; Jackes BR; Irvine AK
    J Mol Model; 2006 Jul; 12(5):703-11. PubMed ID: 16601968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell lines.
    Wu K; D'Amico M; Wang C; Albanese C; Pestell RG; Mani S
    Invest New Drugs; 2005 Aug; 23(4):299-309. PubMed ID: 16012789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide characterisation of the binding repertoire of small molecule drugs.
    Makowski L; Rodi DJ
    Hum Genomics; 2003 Nov; 1(1):41-51. PubMed ID: 15601532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavopiridol binds to duplex DNA.
    Bible KC; Bible RH; Kottke TJ; Svingen PA; Xu K; Pang YP; Hajdu E; Kaufmann SH
    Cancer Res; 2000 May; 60(9):2419-28. PubMed ID: 10811119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
    Shapiro GI; Koestner DA; Matranga CB; Rollins BJ
    Clin Cancer Res; 1999 Oct; 5(10):2925-38. PubMed ID: 10537362
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.